Navigation Links
Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation
Date:2/28/2008

- The following statement was issued by The Mesothelioma Applied Research Foundation (Meso Foundation) to coincide with hearings held by the House Energy and Commerce Committee on the "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act"(HR 3339), today, Thursday, February 28, 2008. The Meso Foundation is urging the House of Representatives to move expeditiously and step-up to the plate in allocating research funds for mesothelioma and

partner with the Meso Foundation in developing effective medical

treatments. -

WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- The Mesothelioma Applied Research Foundation (Meso Foundation) is urging Members of Congress to pass Representative Betty L. McCollum's (D-Minnesota) "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act" (HR 3339) and work with the Senate to get a bill to the President's desk for his signature during this Congressional session.

Today at 12:30 PM EST the House Energy and Commerce Committee will hold a hearing on HR 3339. This is the companion legislation to Senator Patricia Lynn Murray's (D-Minnesota) legislation in the U.S. Senate. The Act is dedicated to late Congressman Bruce Vento, who succumbed to mesothelioma in 2000. (Due to the length of the URL link, please copy and paste into a browser window for the audio webcast: http://energycommerce.edgeboss.net/wmedia- live/energycommerce/11991/100_energycommerce-2322_060901.asx )

Last October, the U.S. Senate unanimously passed Senator Murray's Ban Asbestos in America Act, which prohibits asbestos where present at more than 1% by weight, calls for a public education campaign about the dangers of asbestos exposure, and directs critically-needed federal research to begin to develop treatments for mesothelioma and other asbestos-related diseases.

For decades, asbestos was used heavily in Navy ships and shipyards; in workplaces; in common building materials including drywalls, flooring, roofing materials, and cement pipes; in automotive products like brake pads; and even in common consumer products like hair dryers. As a result, the carcinogen has permeated our homes, offices and schools. The EPA estimates that one asbestos product alone -- a highly toxic "vermiculite" insulation -- is present today in 35 million U.S. homes.

Tens of millions of Americans have already been exposed to asbestos, whether they knew it or not. Ten thousand Americans are now dying each year from past exposures that are too late to prevent.

Deadly exposures will continue long into the future, because of all the asbestos already in our environment and the impossibility of remediating it. The tragedy of 9/11 demonstrates the continued, long-term threat. Estimates of the amount of asbestos released around Manhattan range as high as 1,000 tons. The impact pulverized the asbestos material into microscopic, easily respirable fibers to which the firefighters, rescue workers and other heroes were exposed. In the ensuing months, workers, residents and school children in the area continued to be exposed.

For all those who are now sick, who have already been exposed and are at risk, or who will inevitably be exposed in the future, the only hope is research now to develop effective medical treatments. But research on the asbestos-cancer, mesothelioma, lags far behind other cancers. As a result of the limited treatment options, most mesothelioma patients die within one year of diagnosis.

The Meso Foundation, therefore, is dedicated to promoting the research critically-needed to develop treatments for mesothelioma. As the nation's only independent, scientifically-based source of private mesothelioma research funding, The Meso Foundation has awarded over $5 million in research grants to stellar projects around the world.

Additionally, through the Meso Foundation's advocacy, research funding for asbestos-related diseases has been included in the "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act," which is currently in the hands of Congress. A strong effort on the federal level is needed now to develop treatments for asbestos-cancer. We have accomplished a lot with limited, private funding. It is time for the federal government to partner with us in the search for a cure before more lives are lost.


'/>"/>
SOURCE The Mesothelioma Applied Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
2. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
3. Americas StriVectin the Only Great Serum for Mature, Aging Complexions, Says Leading British Newspaper
4. XCPT(TM) Patient Engagement and Communication Software and DentalXP.com, a Leading Provider of Online Dental Education and Content, Sign a Co-Marketing Agreement
5. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
6. PayFlex Partners With Leading Health Education Company
7. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
8. Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered
9. Kaiser Permanente Recognized With Leading Awards for The Amazing Food Detective Online Video Game
10. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
11. The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... MO (PRWEB) , ... March 28, 2017 , ... ... of job satisfaction in their profession as their value increases in the healthcare ... that provides resources such as job boards, career fairs, and candidate leads to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... clear braces. People who want straight teeth without the extensive time commitment and ... Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible aligners ...
(Date:3/27/2017)... and London UK (PRWEB) , ... March 27, ... ... speed, agility and ability to gain site attention and engagement over the household ... educational webinar will discuss how partnering with the right outsourcing ...
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 Summary ... understand Eli Lilly and its partnering interests and activities since ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ... data. The report will be delivered in PDF ...
(Date:3/27/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... toxicology and efficacy studies. The company is harnessing the ... protein, MAGE A, in an effort to find a ... After 4 weeks of treatment in transgenic mice, ... toxicity in a full toxicology report of various organs. ...
(Date:3/27/2017)... , March 27, 2017 ... 7,000 attendees and more than 600 exhibitors from ... discover opportunities and solutions that will advance the ... April 2017 at the Messe Stuttgart, ... preeminent medical technology platform showcasing the key trends ...
Breaking Medicine Technology: